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ABSTRACT
Yermakoff, Jeannee Karen. M.S., University of Rhode
Island, 1978. An Experimental Model of Hepatic Fibrosis
Induced by the Administration of Dibutyltin Dichloride.
Major Professor: Dr. George C. Fuller.
Dibutyltin dichloride (DBT}, one of a series of dialkyltin derivatives used industrially as polyvinylchloride
stabilizers and urethane catalysts, was investigated for its
I

ability to induce liver fibrosis in rats.
Collagen, the predominant protein in fibrotic tissue,
is synthesized in a series of sequential steps consisting
of assembly of a proline-rich and lysine-rich polypeptide
precursor of collagen, enzymatic hydroxylation of some of
the prolyl and lysyl residues, and glycosylation of some of ·
the hydroxylysyl residues.

Since prolyl residues are not

hydroxylated before they are in peptide-bound form, the
conversion of isotopically labeled proline to hydroxyproline
by prolyl hydroxylase was taken as one parameter reflecting
the rate of collagen formation.

In vitro collagen synthesis

was determined by incubation of liver biopsies with labeled
proline, after which incorporation of label into collagenase
digestible protein is compared to incorporation into collagenase-resistant protein.

Hydroxyproline content served

as a parameter of increased collagen accumulation, since
hydroxyproline does not appear in significant amounts in
noncollagen protein.
ii

DBT was administered by oral intubation (10 and 20 mg/kg)
every other day for 12 days.

Histopathological observation

in these rats revealed extensive inflammation in portal
tracts, bile duct inflammation and proliferation, fibrosis,
necrosis, infarcted areas and granulomatous lesions.

In the

higher dose group, a greater than two-fold increase in
hydroxyproline content, a greater than

50% increase in prolyl

hydroxylase activity and a two-fold increase in relative
collagen synthesis in vitro was observed at the end of the
12 day ·period.
DBT, administered by oral intubation (10 and 2·0 mg/kg)
daily for four days, produced inflammation of portal tracts
and bile duct inflammation and pro.l .iferation.

Prolyl

hydroxylase was increased 50 and 130% over control values
in the · 10 and 20 mg/kg groups, respectively.

In vitro

collagen synthesis increased approximately five-fold in the
higher dose group.

However, there was no increase in

relative collagen synthesis due to a concomitant elevation
in noncollagen protein, probably as a result of inflammatory cell protein synthesis.
DBT (J x 10-7 and J x lo- 6 M) had no effect on prolyl
hydroxylase activity of 1929 mouse fibroblasts in cell
culture.

iii
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INTRODUCTION
The toxicity of alkyltin derivatives has been
recognized for some time.

Intensive investigation of

the biological effects of alkyltin compounds began in
the mid 1950's in response to increased industrial use
of these compounds and a disaster in France caused by
the inclusion of an alkyltin derivative in a preparation
for the treatment of skin infections.

Currently, di-

alkyl tin compounds are widely used as polyvinylchloride ·stabilizers in

medicinall~used

plastics, the biological

inertness of which has been questioned.
Dialkyltin derivatives produce hepatic and biliary
damage (Barnes and Stoner, 1958; Barnes and Magee, 1958;
Gaunt et al., 1968).

Barnes and Magee (1958) reported

hepatic . fibrosis in rats in addition to inflammation and
bile duct injury following the administration of dibutyltin dichloride (DBT).
Hepatic fibrosis has long been recognized as one
of the sequelae of inflammation and chemically-induced
liver damage.

This investigation was conducted to

determine the fibrogenic potential of DBT in rat liver
and the relationship of th-is fibrogenesis to associated
histopathological changes.

In vivo and in vitro labora-

tory models were employed for measurement of hepatic
1
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collagen synthesis following the oral administration
of DBT.

LITERATURE SURVEY

Collagen Biosynthesis
Collagen, the fibrous protein component of connective
tissue, is present in the extracellular matrix as rigid
fibers made up of cross-linked collagen molecules.

These

molecules each consist of three polypeptide chains coiled
into a unique left-handed triple helix•

Five different

types of polypeptide chains, called a. chains, have been
characterized in four different types of collagen (Crystal,
19741 Miller, 1976).

Type I collagen, found primarily in

bone and skin, consists of two

a. 1 chains and one

a. 2

chain, which are distinguishable by their separation on
carboxymethylcellulose columns, and is represented as
[a. 1 (I) ] 2

2.

The remaining three types of collagen each

consist of three identical

a.l chains, with each type of

a. 1 chain differing slightly in amino acid composition.
Type II collagen ([ a.l(II)] ) is found primarily in

3

cartilage; type III ([a. l(III)] ) in fetal tissue, muscle,
3
and aorta; and type IV ([a. l(IV)] ) in basement membranes.
3
Collagen biosynthesis consists of the assembly of
a proline- and lysine-rich polypeptide precursor of collagen,
proc ollagen, which is subse.q uently modified by a number of
J
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post-translational modifications.

Hydroxylation of both

proline (Prockop and Juva, 1965) and lysine (Sinex et al.,
1959) has been shown to occur subsequent to incorporation
of these amino acids into procollagen chains.

Following

hydroxylation of lysine, some of these residues are glycosylated to galactosylhydroxylysine and glucosylgalactosylhydroxylysine (Spiro and Spiro, 1971, 197la, and 197lb).
Cellular processing of procollagen

a chains also

includes interchain disulfide-bond linkage in non-helical
regions of the molecule (Bornstein, 1974) which is essential
for triple-helix formation (Speakman, 1971).

Following the

secretion of procollagen, these non-helical regions are
removed by the extracellular enzyme, procollagen peptidase
(Lapiere et al., 197ls Goldberg et.!!•• 1975).
cross~linking

Collagen

occurs through additional extracellular

processing by the enzyme lysyl oxidase which oxidatively
deaminates specific lysine residues leaving aldehyde
moieties which form cross links through condensation
reactions (Siegal et al., 1970).

Hepatic Fibrosis in Liver Disease
Collagen is the most abundant protein in the human
body and the major protein of connective tissue.

Normal

liver, however, contains only a small amount of connective
tissue.

Hepatic fibrosis defines an excess of collagenous

5
fibrous tissue in the liver (Leevy et al., 1976).

In-

creased collagen content in human and experimental liver
disease leading to cirrhosis has been established by
histological observation and chemical determination of
hydroxyproline (Kent et al., 1959).

Excess collagen

accumulation may occur subsequent to the collapse of
preformed collagen fibers or from formation of new fibers.
However, collapse and

aggreg~tion

of existing fibrous

tissue . following hepatocyte necrosis are thought to play
a minor role in hepatic fibrosis compared to formation of
new fibers (Popper and Udenfrlend, 1970).
de

n.QYQ

Increased

synthesis of collagen has been associated with

the accumulation of collagen in experimental cirrhosis

--

(Huberman .et al., 1969) •
An increase in hepatic collagen may result from one

or a combination of three processes:

increased collagen

biosynthesis; increased maturation (cross-linking), fibril
formation and deposition of collagen; and decreased
catabolism of fibers.
Increased collagen biosynthesis has been demonstrated
as increased activity of the intracellular enzyme prolyl
hydroxylase in experimental (Takeuchi et al., 1976) and
human cirrhosis (Fuller et al., 1976;

Fuller et al., 1977).

Additional evidence for increased collagen biosynthesis
in hepatic fibrosis has been obtained by measurement of

6
in vitro incorporation of labeled proline into collagen
in human (Chen and Leevy, 1976) and experimental (Rodjkind
and Diaz De Leon, 1970) liver biopsies.

Increased collagen

biosynthesis has also been correlated with an increase in
the free proline pool and concomitant decrease in the amount
of free glutamic acid, a precursor of proline, in both
experimental (Rodjkind and Diaz De Leon, 1970) and human
cirrhosis (Kershinobich et al., 1970).

Fibroblasts were

long thought to be responsible for increased collagen biosynthesis in hepatic fibrosis.

Recently, however, enzymes

responsible for collagen biosynthesis have been found in
many nonfibroblastic cell lines in culture (Langness and
Udenfriend, 1974).

In the liver, vitamin A-containing

perisinusoidal cells (Ito cells or lipocytes) have been
implicated in fibrogenesis by serving as resting precursors
of fibroblasts (Kent et al., 1976).
Increased extracellular maturation and deposition
of collagen may occur in hepatic fibrosis due to the
increased availability of surfaces with reduced solid and
fluid exchange, which serve as anchors for collagen fibers
(Popper and Udenfriend, 1970).

Structures which may

contain surfaces such as these include the sinusoidal
surface of damaged hepatocytes and the basement membranes
of proliferated bile ductules and capillaries.
The role of collagen resorption in hepatic fibrosis
remains to be established.

Extracellular collagenase in
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the liver has been observed by immunohistochemical
methods primarily in the liver capsule and portal tracts
(Montfort and Perez-Tamayo, 1975); intracellular collagenase in an active form has been reported to be present
in Kupffer cells of the hepatic reticuloendothelial
system (Fujiwara et al., 197)).

Hepatic collagenase

activity has been reported to be increased in carbon
tetrachloride-induced experimental fibrosis, primarily
in the subacute stage of treatment (Okazaki and Marujama,

1974).
Necrosis and inflammation may be primary stimuli of
fibrogenesis.

The hypothesis that hepatocyte death is

fibrogenic has been accepted for some time (Aterman, 1954).
Hepatic necrosis has been associated with fibrogenesis in
studies with such compounds as carbon tetrachloride
(Cameron and Karunaratne, 1936) and dimethylnitrosamine
(Madden et al., 1970).

Death of hepatocytes has been

thought to cause fibrogenesis by release of either macroor micromolecular products from these cells (Popper, 1975).
Inflammation has been implicated as a precursor to f ibrogenesis.

Pharmacologically active compounds formed by

inflammatory cells may act as stimuli of fibrogenesis
(Popper, 1975).

Immune complexes have been suggested as

stimuli of fibrogenesis, since localization of such complexes in portal tracts preceded the development of
cirrhosis in rats induced by immunization with heterologous sera (Paronetto and Popper, 1966).
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Conversely, necrotic and inflammatory processes
often associated with hepatic fibrosis may be initiated
by the functional changes resulting from collagen accumulation.

Anoxic injury to hepatocytes occurs from

fibrosis and the associated circulatory impairment; the
resulting breakdown products of dead hepatocytes may in
turn be responsible for stimulation of the inflammatory
process.

Organotin Toxicity
Organotin derivatives have demonstrated usefulness
as biocidal compounds, heat stabilizers and catalytic
agents (Piver, 197)).

Dialkyltin compounds are used

primarily as heat stabilizers and catalysts in polyvinylchloride and polyurethane production, respectively;
trialkyl- and triaryltin derivatives are employed as
biocidal agents.

Such applications of organotin compounds

have resulted in increased industrial use whereby these
compounds are now the fourth largest group of organometallics produced.
Dibutyltin derivatives have not been sanctioned by
the Food and Drug Administration for use in plastics
which come in contact with food; dioctyltin compounds
have been developed for this purpose (Piver, 197)).
However, dibutyltin derivatives are widely used as polyvinylchloride stabilizers in medicinally-used plastics.

9
The biological inertness of plastics used in the medical,
dental and pharmaceutical professions has been questioned
(Nimni, 1964; Guess and Stetson, 1968; Guess and Haberman,
1968).

Organotin-containing polyvinylchloride plastics

implanted both intramuscularly. and subcutaneously in
rats and rabbits causes a local tissue reaction manifested by necrosis, proliferation of granulation tissue
and encapsulation by fibrous tissue (Nimni, 1964).
Injection of extracts of these plastics and dilutions
of up to lsl0,000 of dibutyltin dilaurate produced a
similar inflammatory response implicating dibutyltin
dilaurate as the toxic component.

Guess and Haberman

(1968) investigated the toxicity of plastics and their
additives by cell culture techniques.

All ten of the

dibutyltin stabilizers studied demonstrated some degree
of toxicity.
Extensive investigation of the toxicity of organotin
derivatives began in the mid 1950's.

The impetus for

this was the increased industrial use of these compounds
and the "Stalinon" disaster in France in 1954 (Barnes
and .Stoner, 1961).

"Stalinon" was a preparation sold

for the treatment of staphylococcal skin infections,
which was said to contain 15 mg diethyltin diiodide and
100 mg linoleic acid per capsule, but later was found to
contain large quantities of mono- and triethyltin.

The

10
recommended dose was six capsules per day for eight days.
Two hundred and seventeen poisonings resulting in 100
deaths were reported due to "Stalinon".

Symptoms included

persistent headache, vertigo, visual and psychic disturbances, vomiting and abdominal pain.

Autopsy revealed

interstitial cerebral edema and some venous endothelial
proliferation with thrombosis and hemorrhages.
Inves~igation

of a series of alkyltin derivatives

revealed that, with few exceptions, the toxicity of these
compounds increases as the size of the alkyl group decreases and that trialkyl derivatives exhibit greater
toxicity than their dialkyl counterparts (Stoner et al.,
1955).
Trialkyltin compounds have been shown to produce
interstitial edema of the white matter of the brain in
rats (Magee et al., 1957) and inhibit oxidative phosphorylation in vitro (Aldridge and Cremer, 1955; Aldridge and
Street, 1964, 1970, and 1971).

Inhibition of muscular

contractility in vitro associated with disruption of
mitochondria, disorganization of muscle fibers and depletion of neuromicrotubules has also been observed (Tan and
Ng,

1977).
Dialkyltin differ from trialkyltin compounds in that

the primary lesion of these compounds is biliary and
hepatic damage (Barnes and Stoner, 1958; Barnes and Magee,
1958;

Gaunt~

al., 1968).

Dibutyltin is the most active
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of the dialkyltin series in this respect.

Barnes and

Magee (1958) reported bile duct damage and liver inflammation two days after oral administration of dibutyltin
dichloride (50 mg/kg for three days).

After six months,

the bile duct was shortened and thickened and hepatic
portal fibrosis was evident.

EXPERIMENTAL

Animals
Male Long Evans rats weighing 250-350 grams were
purchased from Charles River Breeding Laboratories, Inc.
(Wilmington, MA).

The rats were housed in groups of six

in colony cages at an ambient temperature of 24-27° C.
with alternating 12 hour light/dark cycles.

Rats were

fed Purina Laboratory Chow and water ad libitium.

Materials
Di-n-butyltin dichloride was purchased from
Eastman Kodak Co. (Rochester, NY).

The radioactive amino

acids, 4-3H-proline (specific activity 25-30 Ci/mmole)
and 2,3-JH-proline (specific activity 20 Ci/mmole) were
purchased from New England Nuclear Corporation (Boston,

MA).

Bacterial collagenase, free of nonspecific proteases,

was purchased from Advanced Biofactures (Lynbrook, NY).
Eagles Minimum Essential Medium was obtained from Grand
Island Biological Company (Grand Island, NY).

Analytical

grade reagents were used throughout the investigation.
12

lJ
Cell Culture Technigues
An established line of 1929 fibroblast cells were
maintained in monolayer cultures in Eagles Minimum
Essential Medium with 10% fetal calf serum and chlortetracycline (50 ug/ml).

Treated cell cultures were incubated

with dibutyltin dichloride (0.1 mg/ml in 25% ethanol)
during late log phase at final concentrations of J x 10-? M
and J x 10- 6 M.

Control cultures received equivalent

amounts of 25% ethanol.

After 24 hours, medium was decanted

and cells harvested by centrifugation following the addition
of 0.1% trypsin.

The pellet was washed three times with

phosphate buffered saline and disrupted by ultrasonic
energy (JO watts for two 15 second periods) in 1 ml
0.25 M sucrose.

Prolyl hydroxylase activity was determined

in 50 and 100 ul aliquots of cell sonicates.

Dibutyltin-Induced Hepatic Fibrosis
Fibrosis and associated liver injury was produced
in male Long Evans rats by the administration of dibutyltin dichloride in corn oil by oral intubation.

Dibutyltin

dichloride was administered daily in animals treated for
four days and every two days in animals treated for 12
days.

Rats were sacrificed by decapitation 24 hours after

the last administration of dibutyltin dichloride.

The
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livers were removed and quickly chilled.

Sections of

liver tissue were fixed and prepared for light microscopy
using hematoxylin-eosin and trichrome stains.

Liver

samples were also prepared for determination of prolyl
hydroxylase activity and in vitro collagen synthesis.
Remaining liver tissue was stored frozen for determination
of hydroxyproline content.

Hydroxyproline Determination
Liver hydroxyproline content was determined using
the method of Kivirikko et al. (1967) with some modifications.

Acid hydrolyzates of liver were prepared by

autoclaving 150 mg liver in 4 mls 6 N HCl for 24 hours.
Following hydrolysis, samples were decolorized with activated charcoal, centrifuged at low speed (1000 rpm) and
the resultant supernates filtered.

Using phenolphthalein

as an indicator, samples were adjusted to a pink color
with 1 and 10 N potassium

hydroxide.

Aliquots containing

J-15 ug hydroxyproline and hydroxyproline standards (525 .ug) were diluted to 4 mls.

The pH was again adjusted

using phenolphthalein as an indicator and solutions were
saturated with potassium chloride.

One ml potassium

borate buffer (pH 8.7) and 0.5 ml 10% alanine were added
with mixing.

After JO minutes samples were oxidized with

1 ml 0.2 M chloramine-T solution at room temperature.
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The reaction was stopped after 25 minutes with 3 mls

3.6 M sodium thiosulfate.

Toluene-soluble oxidation

products were extracted in 5 mls toluene and discarded.
Pyrrole was formed from oxidation products of hydroxyproline remaining in solution by heating to 100° C for
JO minutes.

After cooling, pyrrole was extracted with

5 mls toluene.

The addition of 1 ml Ehrlich's reagent

(p-dimethylaminobenzaldehyde) to 2.5 mls extract produced
a pyrrole chromophore after 30 minutes at r .oom temperature
with a characteristic absorbance at 560 mu.

Preparation of Substrate for Prolyl Hydroxylase Assay
The tritium labeled substrate was prepared by the
method of Hutton et al~ (1966) with some modifications.
Twenty-five to thirty dozen, 7-day-old decapitated chick
embryos were placed in ice-cold Krebs-Ringer buffera
(Stone and Meister, 1962).

After washing twice with

ice-cold Krebs, embryos were minced in the presence of
a small amount of ice-cold Krebs.

Five to six gram

portions of minced embryo were placed in 50 ml beakers
and enough Krebs buffer was added to bring the final
volume to 20 mls.

Following the addition of 1.0 mci

aNaCl, 1.285 g; KCl, 0.224 g; MgSO~, 0.144; CaC1 2 ,
0.144 g: KH 2 Po4 , 0.544 g; NaHC0 1 , 2.10 g; D-Glucose,
1.80 g; and distilled water to ~liter.
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4-3H-proline and 20 ul of 1.0 M a ,a -dipyridyl, the
mixture was incubated for two hours at 37° C under
(95/5%) in a metabolic shaker.

o2 -co 2

After two hours, the

embryo minces were centrifuged at J0,000 rpm for 90
minutes and the supernates discarded.

Newly synthesized

collagen was extracted from the pellet with 0.5 M acetic
acid (2 ml/gm tissue) overnight.

After centrifugation

for 90 minutes at J0,000 rpm, the supernate containing
newly-formed, unhydroxylated collagen was dialyzed against
ten volumes of 0.01 M Tris HCl buffer (pH 7.4) with at
least four changes.

The substrate was then autoclaved

for 15 minutes and redialyzed against three changes of 10
volumes of Tris HCl buffer (pH 7.4).

Substrate was then

calibrated for specific activity and linearity with a
standard purified rabbit enzyme (Chichester et al., 1976)
and frozen in 10 ml aliquots.

Prolyl Hydroxylase Activity
Immediately after rats were sacrificed, livers were
removed and 15-25 mg aliquots of tissue were homogenized
in JOO ul of buffer containing 0.25 M sucrose, io-5 M
ethylenediaminetetraacetic acid, 10-5 M dithiothreitol
and 0.01% Triton.

Prolyl hydroxylase activity in 50 and

100 ul aliquots of homogenate was determined by the method
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of Hutton et al. (1966) with some modifications.

Aliquots

of liver homogenates were incubated at 30° C for 30 minutes in a mixture containing approximately 600,000 cpm
(depending on substrate batch) of tritiated substrate
{0,2 ml), 0.5 mM ascorbate, 0.1 mM a-ketoglutarate,
0.1 mM ferrous ammonium sulfate, 0.05 M Tris HCl buffer
(pH 7.4), 0.2% bovine serum albumin and 0.02% catalase,
The prolyl hydroxylase reaction was stopped after 30
minutes by the addition of 0,1 volume 50% trichloroacetic
acid.

Tritiated water was then collected by vacuum distilla-

tion; a measured fraction of tritiated water was counted
for radioactivity in a Packard Tri-Carb Liquid Scintillation
Spectrometer (Model 3310).

This radioactivity reflects

the stoichiometric formation of hydroxyproline and tritiated
water by prolyl hydroxylase in the presence of cofactors
and labeled substrate as described above (Rhoads and
Udenfriend, 1970),

Due to variability in substrate batches,

a conversion factor, derived from substrate calibration
with standard enzyme, is employed to permit comparisons of
prolyl hydroxylase activity values when different substrate
preparations are used.
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In Vitro Collagen Biosynthesis
Collagen and noncollagen protein synthesis by liver
tissue in vitro was determined by the method of Diegelmann
et al. (1975) with modifications.

Approximately 100 mg of

freshly dissected liver minces were incubated for 24 hours
at 37° C under

o2 -co 2

(95/5%) in 4 mls of Eagles minimum

essential medium containing 4-JH- or 2,J-JH-proline (50
uci/ml), 10-4 M ascorbate and 50 ug/ml S -aminoproprionitrile.

Experiments have been conducted confirming that

label incorporation into collagen and noncollagen protein
is linear against time between 6 and 24 hours a the percent
label in collagen does not change during this 24 hours.
The incubation mixture was homogenized in a Bellco glass/
glass homogenizer and protein was precipitated by the addition of 0.1 volume 50% trichloroacetic acid at 4°

c.

The

pellet, collected by centrifugation at 5,000 rpm for JO .
minutes, was resuspended in 0.5 M acetic acid and dialyzed
against 100 volumes of 0.5 M acetic acid with two changes
and against 100 volumes of 0.05 M Tris HCl buffer (pH 7.4)
with two changes to remove unincorporated labeled praline.
Tubes of o.4 ml aliquots of sample were then incubated for
18 hours at J7° C. in a mixture containing 0.05 M Tris HCl
buffer . (pH 7.4), N-ethylmaleimide (2.5 umole), calcium
chloride (0.5 umole), 0.1 ml chloroform and lJO units of
bacterial collagenase.

Duplicate tubes were incubated

without collagenase, which served as enzyme blanks.

19
Following incubation, the reaction was stopped and protein
was coprecipitated with 0.1 volume bovine serum albumin
(1.0% ) by the addition of one volume 10% trichloroacetic
acid.

After JO minutes on ice, samples were centrifuged at

5,000 rpm for JO minutes.

The pellet was digested in 2 mls

DigestolR (Yorktown, Hackensack, NJ) and counted in 10 mls
toluene-based scintillation cocktail.

The 5% trichloro-

acetic acid supernate was again coprecipitated using bovine
serum albumin (1.0%) and counted in 10 mls HydromixR
(Yorktown, Hackensack, NJ).
on liver homogenates.

Protein content was determined

Collagen and noncollagen protein

synthesis per unit protein was calculated from collagenasedigested protein in the supernate and collagenase-resistant
protein in the pellet, respectively.

Relative collagen

synthesis was calculated using a formula which accounted
for the relative enrichment of collagen proline/hydroxyproline content (5.4 times) compared to noncollagen · protein (Diegelmann et al., 1975).

Protein Determination
Protein content was determined by the method of Lowry
et al. (1951) using bovine serum albumin as the protein
standard.

The intensity of the characteristic blue color

was read at 750 mu on a Gilford Model 250 Spectrophotometer.
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Statistical Methods
Students' t-test was used to test for significant
differences between sample means.

The sample means,

standard errors of the means and t-statistics were calculated on an Olivetti-Underwood Programma 101 computer
using the following formulae.
a.)

Arithmetic means of samples

b.)

Estimated standard error of the mean:
"

d'X 1

c.)

=j ., Nsl
-1
1

t-statistica

Acceptable level of significance in these studies was
defined as P < 0.05 for a one-tailed t-test.

RESULTS

Cell Culture Investigation
The effect of dibutyltin dichloride (DBT) on mouse
fibroblasts in cell culture is shown in Table 1.

When

L929 fibroblasts were incubated with DBT at concentrations of 3 x 10-? M and 3 x 10- 6 Mat late log phase,
no change in prolyl hydroxylase activity in cell sonicates
was observed compared to control values.

Liver Hydroxyproline Content
Since hydroxyproline does not appear in significant
amounts in noncollagen protein, the amount of this amino
acid reflects the amount of collagen present in liver
tissue.

The effect of DBT on liver hydroxyproline content

in rats following treatment every two days for 12 days is
shown in Table II.

The amount of hydroxyproline, ex-

pressed as ug/mg liver wet weight, reflects measurement
of the pyrrole chromophore of this amino acid in liver
acid hydrolyzates.

In the 10 mg/kg-treatment group,

there was no change in liver hydroxyproline content.
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TABLE I
Effect of Dibutyltin (DBT) on Prolyl Hydroxylase
a
Activity in L - 929 Cells
Group

Control

prolyl hydroxylase activityb
cpm/ug protein

54
60

DBT (3 x l0- 7M)

56
60

DBT (3 x l0- 6M)

47
64

alate log phase L-929 cells were incubated with DBT for 12 hours.
3
bestimated by the formation of HHO from incubation at 30°C of
4-3H-proline rich substrate and cofactors with 50 and 100 ul
aliquots of cell sonicates prepared a·s : described in the methods.
Each value represents mean of enzyme activity measurements from
one flask of cells reported as cpm/ug protein/30 min.

23
TABLE II
Effect of Dibutyltin (DBT) on Liver Hydroxyproline Content
a
in Rats After 12 Day~ of Treatment
Hydroxyprolinec
ug/mg liver wet weight

Group

Control

6

0.125 + 0.004
(range 0.105 - 0.133)

DBT (10 mg/kg)

7

0.148 + 0.019
(range 0.102 - 0.249)

DBT (20 mg/kg)

6

0.266 + 0.044d
(range O.l57 - 0.447)

~BT in corn oil was administered every 2 days for 12 days by oral
intubation; controls received equivalent amounts of corn oil.
b

c

N represents the number of rats in each group.
determinated colorimetrically in liver acid hydrolyzates as described
in the methods •
Values are mean + S.E.M.

dp

< 0.005 vs. control.
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. However, DBT administration at the higher dose of 20
mg/kg produced a greater than two-fold increase (p < 0.005)
in the amount of hydroxyproline.

Prolyl Hydroxylase Activity
Since prolyl residues are not hydroxylated before
they are in peptide-bound form and hydroxyproline does
not occur to any significant extent in noncollagen
protein, proline hydroxylation can be used as a measure
of collagen synthesis in rat liver tissue.

The effect

of DBT on prolyl hydroxylase activity in rat liver
homogenates after 4 and 12 days of treatment is seen in
Tables III .and IV, respectively.

Arter four days of

DBT treatment, prolyl hydroxylase activity increased
approximately 50'% (p < 0.01) in the 10 mg/kg group and
about 130% (p < 0.01) in the 20 mg/kg group.

Animals

receiving the same doses of DBT every two days for
12 days (Table IV) showed a relatively modest increase
in prolyl hydroxylase activity.

There was no change in

prolyl hydroxylase activity in the 10 mg/kg group and
an increase of approximately
mg/kg group.

50% (p

< 0.05) in the 20
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TABLE III
Effect. of Dibutyltin (DBT) on Liver Prolyl Hydroxylase (PH)
Activity in Rats After 4 Days of Treatment a
PH activity
cpm/mg protein

Group

c

Control

5

1129 + 94
(range 85l-1297)

DBT (10 mg/kg)

5

1760 + 169d
(range 1326-2226)

DBT (20 mg/kg)

5

2537 + 258d
(range 1709-3095)

~BT in corn oil was administered daily. for 4 days by oral intubation;
controls received equivalent amounts of corn oil.
b

N represents the number of rats in each group.

3
cestimated by the formation of HHo from incubation at 30°c of
4-3H-proline-rich substrate and cofactors with 50 and 100 ul
aliquots of liver homogenates prepared as described in the methods
and reported as cpm 3HHo/mg protein/30 min.
Values are mean + S.E.M.
d

P < 0. 01 vs. control •
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TABLE IV
Effect of Dibutyltin (DBT) on Liver Prolyl Hydroxylase (PH)
Activity in Rats After 12 Days of Treatment a
PH activityc
cpm/mg protein

Group
Control

12

DBT (10 mg/kg)

15

DBT (20 mg/kg)

12

2030 + 202
(range 1290 - 3446)
1873 + 95
(range-1310 - 2517)
3379 + 400
(range 1974 - - 6527)

d

~BT in corn oil was administered every 2 days for 12 days by oral
intubation; controls received equivalent amounts of corn oil.

bN represents the number of rats in each group.
cestimated by the formation of 3HHo from incubation at 30°c of
4-3H-proline-rich substrate and cofactors with 50 and 100 ul
aliquots of liver ho~ogenates prepared as described in the methods
and reported as cpm HHO/mg protein/30 min.
Values are mean + S.E.M.
dp < 0.05 vs. control.
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In Vitro Collagen Synthesis
Although prolyl hydroxylase activity is a sensitive
indicator of increased fibrogenesis in liver homogenates,
it has not been shown to be a rate-limiting step in
collagen biosynthesis.

A more direct indication of

absolute and relative collagen synthesis is obtained by
measurement of in vitro incorporation of JH-proline into
collagenase-degradable and collagenase-resistant protein.
The effect of DBT on in vitro collagen synthesis in
rat liver tissue minces after 4 and 12 days of treatment
is shown in Tables V and VI, respectively.

After 4 days

of DBT treatment at a dose of 20 mg/kg, the in vitro incorporation of labeled praline into collagenase-digestible
protein increased approximately five-fold (p < 0,001).
There was a concomitant increase in the amount of label
incorporated into collagenase-resistant protein of approximately the same magnitude.

As a result, no significant

change was observed in the percent of labeled protein
digested by collagenase.

DBT treatment every two days

for 12 days (Table VI) at doses of 10 and 20 mg/kg
produced a significant increase in the percent of collagenase-digestible protein at the higher dose only (p < 0.05).
This increase reflects increased incorporation of labeled ·
proline into collagenase-digestible protein relative to decreased incorporation into collagenase-resistant protein.

TABLE V
In Vitro Collagen Synthesis in Rat Liver Tissue Minces
a
After 4 Days of Treatment With Dibutyltin (DBT)

Group

Nb

Control

4

DBT
(20 mg/kg)

7

a

b

3
2,3 H-proline
released from
liver protein by
collagenase
c
(cpm/mg protein)
644 + 226
3,098

± 367d

3
2,3 H-proline
incorporated into
collagenase-resistant
protein
c
(cpm/mg protein)
283,750 + 164,840
1,606,840

± 185,080d

% of total
labeled protein
digested by
c
collagenase

0.098 + 0.042
0.039 + 0.006

DBT in corn oil was administered daily for 4 days by oral intubation; controls received
equivalent amounts of corn oil .
N represents the number of rats in each group.

c

Collagenase digestion performed on protein obtained by precipitation with 5% trichloroacetic
acid following 24 hour incubation with labeled praline as described in the methods.
Values are mean + S.E.M.
dp < 0.001 vs. control.

N
CX>

TABLE VI
In Vitro Collagen Synthesis in Rat Liver Tissue
a
Minces After 12 Days of Treatment With Dibutyltin (DBT)
3
4 H-proline released
from liver protein
by collagenase
c
(cpm/mg protein)

3
4 H-proline incorporated
into collagenase-resistant
protein
c
(cpm/mg protein)

GROUP

Nb

CONTROL

6

307 + 81

19,200 + 3,000

DBT
7
(10 mg/kg)

157 + 61

11,900

DBT
5
(20 mg/kg)

440 + 75

13,400 + 900d

± 5ood

% of total
labeled protein
digested by
collagenasec
0.300 + 0.081
0 . 282 + 0.100
0.590 + 0.082d

a

DBT in corn oil was administered every 2 days for 12 days by oral intubation; controls received
equivalent amounts of corn oil.

b

N represents the number of rats in each group.

c

Collagenase digestion performed on protein obtained by precipitation with 5% trichloroacetic
acid following 24 hour incubation with labeled proline as described in the methods.
d

P <

0.05 vs . control.

I\)
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Body, Liver and Relative Liver Weights
The effect of four days of DBT treatment (20 mg/kg)
on weight gain is shown in Figure I.

Dibutyltin-treated

rats lost approximately eight grams per day resulting in
a mean body weight which was 26% less (p < 0,001) than
control animals.

After DBT treatment every two days for

12 days, the mean body weight was 12% less (p < 0.05)
than control rats (Table VII).

Histopathology
Dibutyltin treatment at a dose of 20 mg/kg for
four days produced inflammatory and biliary tract changes
in rats.

Inflammatory cells were observed throughout

the portal tracts, most notably in and around bile ducts.
Proliferation of bile ducts was evident at this time.
At a dose of 10 mg/kg for four days, inflammation and
biliary damage was minimal.
After 12 days of DBT - treatment (20 mg/kg), inflammation and biliary damage was extensive.

Both mono-

nuclear and polymorphonuclear cells were present in and
around portal tracts and extending out into parenchyma
leaving only central vein areas preserved.

Bile ducts

were proliferated and congested with polymorphonuclear
cells; damage to the bile duct epithelial cells was
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FIGURE I

Effect of Dibutyltin on Rat Body Weighta
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aDibutyltin in corn oil (20 mg/kg) was administered
every day for 4 days by oral intubation; controls
received equivalent amounts of corn oil.
Values are mean - S.E.M.
bp < 0.01 vs. control
cp < 0.001 vs. control
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TABLE VII

Ef feet of Dibutyltin on
Relative Liver Weights
Group

N

Body~,

a

Body
Weight

Body
Weight

(g)

(g)

Liver and
Relative
Liver Weight b 0 d
(g liver/lOOg weig
.Yht)

Control

6

384 + 14

12.85 + 0.94

3.33 + 0 . 15

DBT
(10 mg/Kg)

7

382 +

13.01 + 0.60

3.40 + 0.12

DBT
(20 mg/Kg)

6

339 + 14b

13.22 + 0.70

3.91 + 0.23

6

~BT in corn oil was administered every 2 days for 12 days by oral

intubation; controls received equivalent amounts of corn oil·
b

P< 0.05 vs. control.
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appreciable.

Areas of necrosis, both focal and confluent,

were seen at this time.

Large infarcted areas and non-

specific granulomatous lesions were present throughout
the parenchyma.

Finally, both periportal and paren-

chymal accumulation of fibrous tissue was demonstrated
by trichrome stain.

Treatment with 10 mg/kg DBT for 12

days produced moderate inflammation and biliary damage,
with minimal fibrosis and necrosis.

DISCUSSION
Biochemical and histological studies of DBT-treated
rat livers after 12 days of treatment reveals increased
accumulation of collagen which is associated with numerous
histopathological changes.

Histological observation of

fibrous tissue and the greater than two-fold increase in
hydroxyproline content following 20 mg/kg DBT treatment
indicates the development of hepatic fibrosis which
has not progressed to cirrhosis.

There is no increase

in hydroxyproline in the 10 mg/kg group and minimal histological evidence of fibrous tissue.

The correlation

between histologically demonstrable fibrous tissue and
biochemically determined collagen is in agreement with
that seen in dietary (Brunner et al., 1973) and carbon
tetrachloride-induced cirrhosis (Rojkind, 1973).
Biochemical data indicate only a moderate increase
in hepatic collagen synthesis at 12 days when extensive
fibrosis and necrosis are already established by histopa thological criteria.
is increased only

The activity of prolyl hydroxylase

50% over controls, and there is no

elevation in the amount of collagenase-digestible protein
synthesized in vitro in liver biopsies.

34

35
The increased collagen accumulation at 12 days can,
however, be attributed to an increase in relative, or
percent, total protein synthesis directed toward collagen
synthesis as a result of a significant decrease in the
synthesis of noncollagen protein.

The percent collagen

synthesis in vitro is a comparison of collagen and noncollagen synthesis per unit of protein.

Histological

observation suggests a decrease in viable areas of parenchyma and an increase in necrotic and fibrous tissue.
This in turn would suggest a decrease in noncollagenprod uc ing cells with a resultant increase in collagen
production per unit of protein.

The two-fold increase

in percent collagen synthesized in vitro shown in DBTtreated livers after 12 days supports this conclusion.
Since significant liver hydroxyproline accumulation
is evident after 12 days of DBT treatment, the effect of
DBT (10· and 20 mg/kg) on collagen synthesis in rat liver
is investigated after only four days of treatment.

Al-

though histological observation of liver biopsies with
a collagen specific stain fails to show evidence of
fibrosis at four days, biochemical studies demonstrate
an increase in collagen synthesis.
Prolyl hydroxylase activity in liver homogenates is
increased greater than 50% and 130% in the 10 and 20 mg/kg
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DBT-treated rats, respectively.

Increased activity of

this enzyme has been shown to precede the increase in
hydroxyproline content in carbon tetrachloride-induced
cirrhosis (Takeuchi et al., 1967) and histological
evidence of advanced cirrhosis in human liver biopsies
(Fuller et al., 1976; Fuller et al., 1977).

The observed

increase of prolyl hydroxylase activity in DBT-treated
rat livers, therefore, suggests that fibrogenesis is
increased at four days, prior to observable collagen
accumulation.
Additional evidence for increased collagen synthesis
after four days of DBT treatment is seen in the six-fold
increase in in vitro synthesis of collagenase-digestible
protein • . There _ is no apparent enrichment in the amount of
protein synthesis - directed to collagen because of a concomitant increase in noncollagen protein synthesis. However, this increase in n.o ncollagen prate in synthesis may
represent the protein made by inflammatory cells detected
by light microscopy.
The effect of DBT on fibroblasts is determined using
monolayer cell cultures of 1929 fibroblasts.

Prolyl

hydroxylase activity is used as a measure of collagen
synthesis in these cells.

A direct correlation between

the activity of this enzyme and the formation of hydroxylated collagen has been reported by Gribble et al . (1969)
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in cell cultures of L929 fibroblasts.

That incubation

with DBT had no effect on the activity of prolyl hydroxylase in 1929 cells suggests that this compound does not
directly stimulate collagen synthesis by fibroblasts
in vivo and that the mechanism of DBT-induced hepatic
f ibrogenesis requires a step intermediate to the direct
stimulation of collagen-producing cells.
The increased f ibrogenesis seen after four days of
DBT treatment appears to be a sequela of inflammation
and/or bile duct injury and proliferation, the only
histopathological changes observed at this time.
Diethyltin dichloride has been shown to decrease
oxygen uptake in rat brain in vitro by binding to sulfhydral groups in a -keto acid oxidases with the resultant
inhibition of these enzymes (Aldridge and Cremer, 1955).
Since the presence of DBT has been demonstrated in the
bile (Barnes and Magee, 1958), and dialkyltin compounds
have many biological properties in common (Stoner et al.,
1954; Barnes and Stoner, 1961), DBT may produce its
biliary damage by decreasing oxygen uptake, thereby producing anoxia in bile duct epithelial cells.
Further support for inflammation in portal tracts
and bile duct damage being the primary lesion of DBT is
presented by the histological picture after 12 days of
treatment where the hepatocyte injury observed is
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primarily peripheral.

At this time, liver injury re-

sembles that of drug-induced hepatitis with necrosis and
fibrosis (Leavy et al., 1976) with the exception of
preserved centrilobular parenchyma.

CONCLUSIONS
(1)

After four days of DBT treatment (20 mg/kg),

histological observation of rat livers showed inflammation
in portal tracts and bile duct inflammation and proliferation.

Prolyl hydroxylase activity was increased 50 and

1JO% over control values in the 10 and 20 mg/kg groups,
respectively.

The amount of in vitro collagen synthesis

was increased five-fold in the higher dose group.

There

was, however, no change in percent collagen synthesis
since noncollagen protein synthesis was also elevated
five-fold, probably as a result of inflammatory cell
protein synthesis.

The data obtained indicate increased

fibrogenesis at four days time although there is no
evidence of fibrosis by histopa..thological criteria.

(2)

After 12 days of DBT treatment (20 mg/kg),

there was extensive mononuclear and polymorphonuclear
cell infiltration in portal tracts, particularly in and
around bile ducts, and within the parenchyma.

Unlike

other forms of drug-induced hepatic injury, the central
vein areas were preserved.

There were focal and confluent

areas of necrosis, infarcted areas, nonspecific granulomatous lesions and an accumulation of fibrous tissue.
)9
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Increased collagen content was also reflected by ·the
two-fold increase in hydroxyproline content.
hydroxylase activity was elevated only

Prolyl

50% over con-

trols and in vitro collagen synthesis was unchanged
af'ter 12 days of treatment.

However, percent collagen

synthesis was increased two-fold.

(J)

DBT (J x 10-7 and J x lo- 6 M) had no effect

on prolyl hydroxylase activity of mouse fibroblasts
in cell culture.

(4)

These results suggest that DBT-induced

fibrogenesis is not a result of direct stimulation
of fibroblasts and that biliary damage and/or inflammatory processes are responsible for increased f ibrogenesis and associated histopathological changes.
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